Due to their simplicity and flexibility of genomic construction, herpes simplex virus (HSV) ampliconbased vectors are attractive vehicles for gene delivery. However, a significant problem faced in the generation of amplicon stocks is the low amplicon to helper virus (A/H) ratio. In order to improve the proportion of amplicons generated, a selection system for amplicon production was developed in which the HSV thymidine kinase (TK) gene is inserted into an amplicon plasmid and an HSV mutant with both TK and glycoprotein H (gH) genes deleted is
Introduction
Herpes simplex virus (HSV) has some unique features and vectors derived from it have great promise in gene delivery. HSV has a very wide host range and cell tropism (Boothman et al., 1989 ; Roizman, 1990 ; Breakefield & DeLuca, 1991 ; Leib & Olivo, 1993) . It has been shown that HSV can infect essentially every cell type in most vertebrates which have been examined. In addition, the natural property of the virus to infect and establish latent infection indefinitely in post-mitotic neurones has generated substantial interest in using it to deliver therapeutic genes to the nervous system. There are two types of HSV-based vectors : foreign genes can either be inserted into a backbone virus genome (recombinant virus) or into an HSV amplicon-based vector. The development of amplicon vectors originates from studies of naturally occurring defective viruses during high-multiplicity virus propagation (Frenkel, 1981 ; Frenkel et al., 1982 ; Spate & Frenkel, 1982 ; Stow et al., 1983) . A typical amplicon contains a copy of an HSV replication origin (oriS) and a packaging signal sequence located in the repeated ' a ' sequence of the HSV genome (Vlazny & Frenkel, 1981 ; Spate & Frenkel, 1982 ; Stow, 1982 ;  Author for correspondence : Xiaoliu Zhang.
Fax j44 1223 424115. e-mail xzhang!cantab.co.uk used as a helper virus. Using a protocol in which amplicon stocks are passaged 2-3 times in BHK cells of TK N and gH M genotype in the presence of selection medium containing methotrexate, stock preparations with high A/H ratio (up to 5 : 1) and high amplicon titre ( 1i10 9 infectious units/ml) were generated. In vitro characterization demonstrated that a high level of biologically functional products can be efficiently produced from these amplicon constructs. Kwong & Frenkel, 1984) . Once introduced into suitable cells together with helper virus, the helper virus provides trans replication and packaging functions. The amplicon genome can then be amplified, presumably by a rolling-circle mechanism, and packaged. These packaged amplicon-containing viral particles are in effect defective virions, containing multiple copies of the amplicon sequences in a concatemeric form, and are able to infect mammalian cells. Foreign genetic material inserted into the amplicon plasmid can therefore be efficiently introduced into target cells by infection.
A major problem facing the development of amplicon technology for gene delivery is the difficulty of generating a stock with a high amplicon titre and sufficiently high amplicon to helper virus (A\H) ratio (Glorioso et al., 1992 ; Ho, 1994) . Attempts to improve the efficiency of amplicon packaging, including procedures such as incorporating the SV40 DNA replication origin into an amplicon construct and pre-replicating it in COS cells before packaging, have met with little success (Wu et al., 1995) . Fraefel et al. (1996) have recently reported a procedure for generating helper virus-free amplicon stocks in which the whole HSV viral genome was fragmented and cloned into a few cosmid vectors. By co-transfecting an amplicon plasmid with these HSV sequence-containing cosmids, a stock free of detectable helper virus could be made. However, the amplicon titre in such preparations is low and the X. Zhang and others X. Zhang and others stock cannot be further passaged for expansion. More recently, a selection system based on inserting an essential gene from HSV and using a mutant HSV with that essential gene deleted as helper virus, a so-called ' piggyback ' system, has been reported for raising the A\H ratio (Pechan et al., 1996) .
Here, we report the development of an alternative selection system for amplicon production, in which the HSV thymidine kinase (TK) gene is inserted into an amplicon and a TK − glycoprotein H (gH) − HSV mutant is used as a helper virus. Using a protocol in which the initial transfection\super-infection harvest was passaged in BHK TK − gH + cells in the presence of selection medium containing methotrexate, stock preparations with high A\H ratio (up to 5 amplicon to 1 helper virus) and high amplicon titres (more than 1i10*) were achieved. (Boursnell et al., 1997) . These cell lines carry the genes encoding the gH of HSV-1 (CR-1) and HSV-2 (CR-2), respectively. These cells therefore serve as complementing cells for growing the gH-deleted virus which, in non-complementing cells, is a disabled infectious single-cycle (DISC) virus. The BHK TK − gH + cell line was established by transforming the parental BHK TK − cells with a plasmid containing the HSV-1 gH gene (C. Entwisle and others, unpublished data). CR-1 and CR-2 cells were grown in DMEM medium plus 10 % FCS and BHK cells were grown in Glasgow Modified Eagle's Medium (GMEM) supplemented with 5 % tryptose broth and 10 % FCS.
Methods
HSV-1 strain SC16 is a well-characterized clinical isolate with a low passage history (Hill et al., 1975) . PS1, which was used in this study as helper virus for generating amplicon stocks, is a deletion mutant derived from HSV-1 strain SC16. The deletion covers the gH gene and part of the TK gene. (This virus was kindly supplied by P. Speck, Northwestern University Medical School, Chicago, USA). HSV-2 strain HG52 (a gift from Moira Brown, MRC Institute of Virology, Glasgow) is a strain with low neurovirulence. A gH deletion mutant of this virus, dH2A, has been described elsewhere (Boursnell et al., 1997) . To make a recombinant DISC expressing IL-2, a gene cassette containing a copy of the human IL-2 gene driven by the CMV immediate early promoter was inserted into the virus by direct ligation into a unique PacI site engineered into the gH locus (M. Boursnell and others, unpublished data) . All the DISC virus stocks were grown and titrated on CR-1 or CR-2 cells.
Construction of amplicon plasmids. The basic amplicon plasmid pW7TK ( Fig. 1) was constructed by inserting an HSV-1 TK gene cassette (i.e. the 2 kb PvuII-BamHI fragment from HSV-1 strain 17 BamHI Q fragment) into the pW7 plasmid which contains an HSV-1 replication origin (oriS) and the packaging signal (Stow et al., 1983) . The construction of amplicon plasmids containing the human papillomavirus E6\7 fused gene or human IL-2 (hIL-2) gene was carried out in two steps. Initially, the E6\7 or hIL-2 coding sequences were cloned into pRc\CMV (Invitrogen) so that the genes were driven by the CMV immediate early promoter. Then the cassettes containing the promoter, the gene and the poly(A) signal were cloned into the unique SapI site in pW7TK by blunt-end ligation. For constructing the amplicon containing the green fluorescent protein (GFP) gene, a cassette consisting of GFP driven by the CMV promoter contained in the plasmid pEGFP-N1 (Clontech) was ligated into the SapI site of pW7TK by blunt-end ligation.
Amplicon stock preparations. Initially, amplicon plasmid DNA was transfected into CR-1 cells either by calcium phosphate-precipitation or by lipofectamine (Gibco-BRL). Briefly, cells were seeded 1 day before transfection in 5 cm Petri dishes. For the calcium phosphate precipitation, 8 µg DNA was mixed with 0n5 ml HEPES buffered saline (HEBS) pH 7n05 and 70 µl 2 M CaCl # at room temperature for 30 min. The culture medium was removed and the DNA precipitate was added to the cells. The cells were incubated at 37 mC for 40 min before the transfection mixture was removed and replaced with 4 ml GMEM plus 5 % FCS. Cells were incubated at 37 mC for another 4 h before treatment with 1 ml 25 % DMSO in HEBS for exactly 4 min. The DMSO solution was then removed and cells were washed with serum-free medium. Five ml GMEM plus 5 % FCS was added and the cells were incubated at 37 mC for another 16 h. The lipofectamine transfection was carried out according to the supplier's instructions. Briefly, 2 µg amplicon plasmid DNA was added to 200 µl sterile H # O and 10 µl lipofectamine was diluted 20-fold in sterile H # O. The DNA and lipofectamine solutions were mixed together gently and left at room temperature for 30 min. Then 1n6 ml OptiMEM medium (supplied by the manufacturer, Gibco-BRL) was added to the DNA-lipofectamine mixture. Cells were rinsed with serumfree medium and the DNA-lipofectamine mixture was laid gently over the cells. After incubation for 5 h at 37 mC, the transfection solution was removed and replaced with 5 ml GMEM plus 5 % FCS. Cells were incubated at 37 mC for another 16 h and then infected with 1 p.f.u. PS1 per cell for another 24 h. Viruses were harvested and titrated by plaque assay. This virus stock was further passaged in BHK TK − gH + cells 2-3 times. For each passage, cells were infected with 3-5 p.f.u. virus per cell (based on the titre of PS1) for 1 h. Then a selection medium containing 0n6 µM methotrexate and 1iTGAG (40iTGAG : 0n6 mM thymidine, 3n8 mM glycine, 9 mM adenosine, 1n9 mM guanosine) was added and the infected cells cultured at 37 mC for 24-28 h before harvesting and titration.
DNA extraction and analysis. Packaged virion DNA was prepared from cell-culture supernatants harvested from infected cells as described previously (Zhang et al., 1994) . Briefly, viral particles were HSV amplicon preparation and gene delivery HSV amplicon preparation and gene delivery pelleted by centrifuging the supernatant at 27 000 g for 2 h. The viral pellet was resuspended in 1 ml TE (10 mM Tris, 1 mM EDTA, pH 8n0). For releasing viral DNA from the viral particles, SDS was added to a final concentration of 0n1 % and proteinase K to 50 µg\ml. The sample was incubated at 37 mC for 4 h. Viral DNA was gently extracted three times with phenol-chloroform, followed by ethanol precipitation. DNA was resuspended in TE and digested with the restriction enzyme AseI. The digested DNA was loaded onto a 0n8 % agarose gel, which was electrophoresed overnight. The gel was stained with ethidium bromide and photographs were taken with both Polaroid Film 667 (for hard-copy) and 665 (for negative film). The image in the negative film was scanned and quantified using a Personal Densitometer SI (Molecular Dynamics).
ELISA assay of hIL-2. Ninety-six well plates were coated with anti-hIL-2 monoclonal neutralizing antibody (R&D Systems) overnight at 4 mC. The coated wells were then blocked with 300 µl 1 % BSA in PBS at 37 mC for 1 h. For preparing the standard IL-2 solution, 10 µl of 10 µg\ml stock IL-2 (R&D Systems) was added to 9n99 ml medium (MEMj2n5% FCS) to give 10 ng\ml IL-2 solution, From that solution a series of twofold dilutions of IL-2 starting from 25 pg\ml up to 400 pg\ml, together with the diluted samples, were added to the wells. Plates were incubated at 37 mC for 1 h. Biotinylated anti-human IL-2 antibody (R&D Systems, 75 µl) reconstituted in PBS to give 50 µg\ml, was added to each well and the plates incubated at 37 mC for 1 h. Then 15 µl Streptavidin-HOURP (Zymed HOURP, 1\1000 dilution) was added to each well and the plates were incubated at 37 mC for 30 min. One hundred µl o-phenylenediamine (Sigma) was added and the reaction left at room temperature for 10 min before 50 µl 1 M sulphuric acid was added to all wells to stop the reaction. The result was read at 492 nm using the Multicalc program with Titertek Multiskan MCC\340, MKII.
Results

Rationale for the TK selection system
The basic amplicon plasmid pW7TK (Fig. 1) , which was used to construct all the other amplicon plasmids reported in this study, contains in its genome the HSV-1 TK gene in addition to the HSV-1 replication origin (oriS) and packaging signal. Transcriptional units containing promoter, gene of interest and poly(A) were inserted into the unique restriction enzyme SapI site as shown in Fig. 1 . The helper virus PS1 is a genetically mutated HSV-1 and lacks both gH and TK genes (P. Speck and others, unpublished data). The rationale for the TK selection system for amplicon packaging is shown in Fig. 2 . The initial stock prepared from transfection\super-infection usually contains mainly helper virus. Further passage of this stock at moderately high m.o.i., such as 5 p.f.u. per cell, has three outcomes : (1) cells infected by helper virus alone (normally the majority of cells), (2) a small percentage of cells (depending on the ratio of amplicon\helper virus in the inoculum) infected by both amplicon and helper virus, and (3) a very small proportion of cells infected by amplicon alone. Under methotrexate selection, the helper virus amplification in the first category will be eliminated or heavily inhibited. Theoretically, only cells in the second category, which are infected by both amplicon and helper virus, will support virus growth. So this system allows amplicon amplification but inhibits the growth of the majority of helper virus during consecutive passages. 
Amplicon packaging in the selection medium for TK
The concentration of methotrexate used in the selection media was initially determined by testing the inhibition of helper virus growth in both BHK TK − gH + cells which lack endogenous TK, and in CR-1 cells which show endogenous TK expression. Cells were infected at 1 p.f.u. helper virus PS1 per cell for 1 h. Then medium containing increasing amounts of methotrexate was added. Virus was harvested 24 h after infection and titrated by plaque assay. The results in Fig. 3 showed that methotrexate at a concentration up to 2n4 µM did not obviously inhibit helper virus growth in CR-1 cells. On the other hand, it showed a dose response in inhibiting helper virus BCH X. Zhang and others X. Zhang and others growth in BHK TK − gH + cells. The input helper virus titre did not show any increase when medium containing 0n6 µM methotrexate was used, and showed a slight decrease when higher methotrexate concentrations were used. Methotrexate at a concentration of 0n6 µM was therefore used in the selection medium. The results also showed that CR-1 cells support helper virus growth almost one order of magnitude better than BHK TK − gH + cells.
For generating HSV amplicon stocks, CR-1 cells were initially transfected with the DNA of amplicon plasmid pE6\7 (which contains a fusion of the human papillomavirus type 16 E6 and E7 genes), by calcium phosphate precipitation. Twentyfour hours later, cells were super-infected with 1 p.f.u. helper virus PS1 per cell for 1 h. Viruses were harvested 24 h after helper virus infection. These initial stocks were then consecutively passaged in BHK TK − gH + cells at 5 p.f.u. helper virus per cell, in medium with or without methotrexate. Helper virus from each passage was titrated by plaque assay. The amplicon titre was estimated by comparing the amounts of DNA retrieved from packaged amplicon particles with those from helper virus by gel electrophoresis. As illustrated in Fig.  4 , the restriction enzyme AseI cuts the helper virus genome twice, generating two major DNA fragments with sizes of 125 kb and 26 kb, which account for 99 % of the viral genome. AseI cuts most amplicon plasmids only once, generating a much smaller DNA fragment (depending on the size of the individual amplicon construct ; in the case of pE6\7 it is 9 kb), which can be easily separated from the viral DNA fragments by ordinary agarose gel electrophoresis. After ethidium bromide staining of the gel, photographs were taken using both negative and positive films and the amount of DNA in each DNA band shown in the negative film was quantified by densitometer scanning, and used for amplicon titre estimation. If there are equal amounts of amplicon and helper virus, they will contain equal numbers of genome copies and hence an equal mass of DNA. These equal masses of DNA will give the same intensities of ethidium bromide staining regardless of the size of the fragment after AseI digestion. So the ratio of Fig. 5 (a) , quantified by densitometer scanning. † Estimated by multiplying the helper virus titres by the A\H ratio. 
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amplicon to helper genomes can be estimated by comparing the total staining intensity of the multiple copies of the 9 kb amplicon band (see Fig. 4 ) to the total staining intensity of the two helper virus bands. As the helper virus from each stock has been titrated by plaque assay, the inferred amplicon titre (given as infectious units, IU) can therefore be estimated. Fig. 5 a shows the DNA fragment patterns from each passage during the TK selection. The harvest from the initial transfection\ super-infection had barely detectable amplicon DNA. However, the intensity of the amplicon DNA fragment increased during the serial passages. By the second passage, the band representing packaged amplicon was substantially stronger than that from helper virus. The DNA bands were quantified by densitometer scanning. The amplicon titres estimated from the quantification, together with the titres of helper virus, are shown in Table 1 . The results show that, during the serial passages, as the A\H ratio increased, the estimated amplicon titres also increased steadily. So the total stock was expanded while the A\H ratio was improved during the selection. The increase in A\H ratio was more obvious at earlier passages when the inoculated stocks had a very low percentage of amplicon and started to plateau out when the ratio was over 1 : 1. On the other hand, the A\H ratio in the stocks from passages carried out in the ordinary medium without methotrexate did not improve and the DNA band representing amplicon remained invisible even at the third passage (Fig. 5 b) . In order to further amplify the stock and improve amplicon titre, the harvest from the third passage was passaged again, but in CR-1 cells, which had been found to support virus growth more efficiently (Fig. 3) . CR-1 cells were infected at different m.o.i. and the viruses were harvested 24 h after infection and titrated. The A\H ratio was again estimated by DNA analysis. The results in Table 2 show that, although the A\H ratio dropped slightly, the amplicon titre increased more than 100-fold and the estimated amplicon titre reached 2n4i10* IU\ml.
In order to verify the accuracy of amplicon titre estimation by DNA analysis, an amplicon plasmid containing the GFP gene was constructed and a stock was subsequently generated. The helper virus titre was again determined by plaque assay. The amplicon titre was estimated either by DNA analysis as mentioned above or by titration in Vero cells by counting green fluorescent cells under UV light. The amplicon titres obtained from these two different detection methods showed a discrepancy of less than twofold (data not shown).
In vitro gene expression from amplicon constructs
Gene expression from an amplicon construct containing the hIL-2 gene driven by the CMV immediate early promoter, pW7IL-2, was determined and compared with hIL-2 released from a recombinant DISC HSV-2 containing the identical hIL-BCJ X. Zhang and others X. Zhang and others 2 gene cassette in the gH locus (dH2H). Infectious pW7IL-2 amplicon stocks were prepared as described and the A\H ratio was determined by DNA analysis to be 2 : 1. CR-1 cells were infected with either 3 IU\cell of pW7IL-2 (in this case the m.o.i. for the helper virus was 1n5 p.f.u. per cell) or 3 p.f.u. per cell of dH2H. Culture medium was collected at 4 h and 20 h after infection, respectively, and the hIL-2 released into the medium was quantified by an ELISA assay (detailed in Methods). The results in Fig. 6 show that, at 4 h after infection, pW7IL-2-infected cells had already produced a significant amount of hIL-2, while the hIL-2 released from the recombinant virus-infected cells was undetectable by this method. By 20 h after infection, hIL-2 released from pW7IL-2-infected cells reached more than 100 ng per 10' cells. This is almost 20-fold higher than that from dH2H-infected cells. The hIL-2 produced from these infected cells has also been demonstrated to be biologically functional (data not shown).
Discussion
As compared with recombinant HSV viruses, HSV amplicon-mediated gene delivery has some unique features. Amplicon-based vectors are simple to construct, whereas the generation of recombinant HSV is time-consuming and technically challenging. Unlike recombinant viruses, amplicon infection per se is not toxic to the target cells. Therefore gene delivery by HSV amplicons may be safer and also more suitable for long-term gene expression (Geller et al., 1993 ; During et al., 1994 ; Smith et al., 1995) . However, one of the major problems facing amplicon technology is the great variation in amplicon to helper ratios generated in stock preparations ; in general amplicons usually constitute the minor component within stocks compared with helper virus. In this study we have reported a TK selection system for amplicon stock preparation. Under this selection system, the amplicon to helper virus ratio was efficiently elevated to between 1 : 1 and 5 : 1 during serial passages starting with initial stocks which contained barely detectable amplicon particles. Subsequent passage of stocks with high A\H ratio in CR-1 cells without methotrexate selection generated high amplicon titre preparations with the elevated A\H ratio largely maintained.
A recent publication has described a similar ' piggyback ' amplicon packaging system (Pechan et al., 1996) . In this system, a gene essential for HSV replication, IE3, is cloned into an amplicon, and a mutant virus deleted in the same essential gene (d120) is used as helper virus. Whilst stocks with high A\H ratio were produced, fully replication competent revertants were also generated, albeit at low frequency. The helper virus PS1 used in the current study is a double deletion mutant. In addition to the deletion of the TK gene, it also has the gene encoding gH deleted. The gH protein is an essential glycoprotein which is required for virus entry and spread (Gompels & Minson, 1986 ; Forrester et al., 1992) . In noncomplementing cells, the gH deletion mutant can only undergo a single round of replication and the progeny released are no longer infectious (Desai et al., 1988 ; Forrester et al., 1992) . It might be expected that the frequency of generation of revertants containing the TK gene during the current amplicon stock preparation will be similar to the frequency by which the IE3 gene is picked up by d120 in the ' piggyback ' system (Pechan et al., 1996) . However, these TK-containing helper viruses will still lack gH and therefore the safety of this amplicon-mediated gene delivery is maintained.
Finally, when gene expression from an amplicon construct containing the human IL-2 gene is compared with that from a recombinant HSV containing the identical gene cassette, the former construct gives a much higher level of hIL-2 release into the culture medium. This may be due to the unique property of its multiple copy gene delivery (on average, each packaged amplicon viral particle contains 15 copies of the gene of interest, compared with only one copy contained in each of the recombinant viral particles).
